Understanding denaturation is essential for designing effective nanomaterials for biomedical applications. For example, when developing drug delivery systems, it is crucial to ensure that the therapeutic proteins or peptides do not denature upon interaction with the nanocarriers. Additionally, denaturation can affect the biocompatibility and toxicity of nanomaterials, influencing their safety and efficacy in medical applications.
